Alessandro de Nicola
Vorsitzender bei AVIO S.P.A.
Aktive Positionen von Alessandro de Nicola
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AVIO S.P.A. | Vorsitzender | - | - |
| NEXTRA INNXTR INV | Direktor/Vorstandsmitglied | - | - |
| Independent Dir/Board Member | - | - | |
| The Adam Smith Society | Präsident | 01.01.1993 | - |
Orrick, Herrington & Sutcliffe (Italy)
 Orrick, Herrington & Sutcliffe (Italy) Miscellaneous Commercial ServicesCommercial Services Part of Orrick, Herrington & Sutcliffe LLP, Orrick, Herrington & Sutcliffe (Italy) is a legal services provider. The company is based in Milan, Italy. | Corporate Officer/Principal | - | - |
Karriereverlauf von Alessandro de Nicola
Ehemalige bekannte Positionen von Alessandro de Nicola
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LEONARDO S.P.A. | Direktor/Vorstandsmitglied | 15.05.2014 | - |
| Independent Dir/Board Member | 15.05.2014 | - | |
| MOLMED S.P.A. | Direktor/Vorstandsmitglied | 07.07.2010 | - |
| Independent Dir/Board Member | 16.03.2011 | - |
Ausbildung von Alessandro de Nicola
| Università Cattolica del Sacro Cuore Campus di Milano | Graduate Degree |
Statistik
International
| Italien | 8 |
Operativ
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
| Graduate Degree | 1 |
Sektoral
| Electronic Technology | 3 |
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| LEONARDO S.P.A. | Electronic Technology |
| AVIO S.P.A. | Electronic Technology |
| Private Unternehmen | 4 |
|---|---|
AGC Biologics SpA
 AGC Biologics SpA Pharmaceuticals: MajorHealth Technology AGC Biologics SpA engages in the research, development, manufacturing, and clinical validation of cell and gene therapies for the treatment of cancer and rare diseases. Its approach is based on finding drugs that target the reduction of tumor mass in the acute stage, as well as on the provision of selective therapies to eliminate the residual disease. It also conducts cell and gene therapy projects in collaboration with third parties, offering resources and expertise covering preclinical to Phase III trial activities. The company was founded by Claudio Bordignon on July 11, 1996 and is headquartered in Milan, Italy. | Health Technology |
| The Adam Smith Society | |
Orrick, Herrington & Sutcliffe (Italy)
Orrick, Herrington & Sutcliffe (Italy) Miscellaneous Commercial ServicesCommercial Services Part of Orrick, Herrington & Sutcliffe LLP, Orrick, Herrington & Sutcliffe (Italy) is a legal services provider. The company is based in Milan, Italy. | Commercial Services |
Amundi Re Italia
 Amundi Re Italia Investment Trusts/Mutual FundsMiscellaneous Amundi Re Italia is a closed-end investment fund. It operates as a real estate fund. The company is headquartered in Milan, Italy. | Miscellaneous |
- Börse
- Insiders
- Alessandro de Nicola
- Erfahrung
